Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,89%
1 083,04
-9,76
-0,89%
1 092,801 093,681 094,851 081,97
SIXC
Communications
SIXC
Communications
SIXC
-0,39%
602,38
-2,36
-0,39%
604,74604,74605,10601,34
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1 242,83
+28,03
+2,31%
1 214,801 220,811 243,821 220,81
SIXI
Industrials
SIXI
Industrials
SIXI
-0,62%
1 713,82
-10,75
-0,62%
1 724,571 727,021 732,301 707,43
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
639,43641,58644,53637,50
SIXR
Staples
SIXR
Staples
SIXR
-0,20%
837,46
-1,69
-0,20%
839,15836,90840,48832,89
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,65%
214,22
-1,40
-0,65%
215,62215,62216,21213,48
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 204,38
+24,86
+0,78%
3 179,523 191,503 205,093 177,75
SIXU
Utilities
SIXU
Utilities
SIXU
-1,23%
925,38
-11,53
-1,23%
936,91935,42937,17923,20
SIXV
Health care
SIXV
Health care
SIXV
-0,69%
1 442,71
-10,06
-0,69%
1 452,771 445,931 447,431 434,91
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,16%
2 361,34
-3,84
-0,16%
2 365,182 353,642 368,102 347,80
Q1 2026 daromadi • nashr etilgan • Aksiya boʻyicha daromad kutilganidan yuqori +16,23% • Daromad kutilganidan yuqori +5,14%
Natijalarini ochish
TEVA:NYSE
Teva Pharmaceutical Industries Ltd
35,38 US$
+11,89%
(+3,76) 1K
35,01 US$
-1,05% (-0,37)
Birjadan oldin
Savdolar yopilgan: 29-apr, 16:00:05 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
TEVA tikeri uchun statistika yaratilmoqda...
Ochish
34,00 US$
Yuqori
35,62 US$
Past
33,92 US$
Bozor kapitali
40,93 mlrd
Oʻrtacha hajm
5,95 mln
Hajmi
621,00
P/E koeffitsiyenti
29,18
52 haftalik eng yuqori
37,34 US$
52 haftalik eng past
14,16 US$
Aksiya boʻyicha daromad
1,21 US$
Beta
0,76
Muomaladagi aksiyalar
1,16 mlrd
Xodimlar soni
32 ming
Yangiliklar
Internetdagi manbalardan
Profil
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Teva Pharmaceutical Industries Ltd haqida
CEORichard Francis
Xodimlar soni32 ming
Asos solingan13-fev, 1944
Bosh ofislar-
Sektor-
Veb-saytteva.co.il
Oxirgi hisobot
29-apr, 2026
Moliya davri
Ch.1 2026
Normallashtirilgan EPS / Taxminiy
0,53/ (0,46 taxm.)USD
+16,23%musbat
Daromad / Taxminan
3,98 mlrd/ (3,79 mlrd taxm.)USD
+5,14%musbat
Q1 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
3,89 mlrd
4,18 mlrd
4,48 mlrd
4,71 mlrd
Sotilgan mahsulotning tannarxi
2,01 mlrd
2,07 mlrd
2,18 mlrd
2,06 mlrd
Daromad narxi
2,01 mlrd
2,07 mlrd
2,18 mlrd
2,06 mlrd
Tadqiqot va ishlanmalarga xarajatlar
247,00 mln
244,00 mln
256,00 mln
267,00 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
919,00 mln
959,00 mln
973,00 mln
1,12 mlrd
Operatsion xarajatlar
1,17 mlrd
1,21 mlrd
1,24 mlrd
1,37 mlrd
Jami operatsion xarajatlar
3,18 mlrd
3,28 mlrd
3,41 mlrd
3,43 mlrd
Operatsion daromad
709,00 mln
894,00 mln
1,07 mlrd
1,28 mlrd
Boshqa nooperatsion daromad
47,00 mln
-90,00 mln
-27,00 mln
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
294,00 mln
204,00 mln
648,00 mln
90,00 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
482,00 mln
643,00 mln
832,00 mln
1,08 mlrd
Daromad soligʻi boʻyicha xarajat
74,00 mln
-78,00 mln
214,00 mln
-390,00 mln
Amaldagi soliq stavkasi
25,17%
-38,24%
33,02%
-433,33%
Boshqa operatsion xarajatlar
2,00 mln
5,00 mln
9,00 mln
-17,00 mln
Sof foyda
214,00 mln
282,00 mln
433,00 mln
480,00 mln
Sof foyda marjasi
5,50%
6,75%
9,67%
10,19%
Har bir aksiya foydasi
0,52
0,66
0,78
0,96
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
92,00 mln
Foizlarni toʻlash xarajatlari
-212,00 mln
-220,00 mln
-205,00 mln
-280,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-212,00 mln
-220,00 mln
-205,00 mln
-188,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
953,00 mln
1,14 mlrd
1,32 mlrd
1,54 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-2,00 mln
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil